Kobaltrii IV 250, from Bayer Pharmaceutical (Bayer Yakuhin, Ltd.), contains Octocog beta (genetical recombination), a recombinant human blood coagulation factor VIII used to treat bleeding tendency in hemophilia A patients. It is supplied as 250 IU 1 bottle with dissolving liquid (YJ code: 6343447D1025).
Kobaltrii IV 250
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →